Detalhe da pesquisa
1.
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
PLoS Pathog
; 18(6): e1010658, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759511
2.
An introduction to the Marburg virus vaccine consortium, MARVAC.
PLoS Pathog
; 18(10): e1010805, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227853
3.
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Front Immunol
; 14: 1216225, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731485
4.
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs.
NPJ Vaccines
; 8(1): 91, 2023 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37301890
5.
A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease.
Vaccines (Basel)
; 10(7)2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891170
6.
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.
Vaccine X
; 1: 100009, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384731
7.
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.
Int J Infect Dis
; 8 Suppl 2: S31-44, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15491873